摘要 |
This invention is directed to inhibitors of copper-containing amine oxidases (E.C.1.4.3.6) including semicarbazide-sensitive amine oxidase (SSAO; also known as vascular adhesion protein- 1, VAP-I), and their therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer. |
申请人 |
GENMEDICA THERAPEUTICS SL;OLARTE, ANTONIO ZORZANO;MIAN, ALEC;CLAUZEL, LUC MARTI;EXPOSITO, MIRIAM ROYO;FONT, FRANCESC YRAOLA;PALOMERA, FERNANDO ALBERICIO |
发明人 |
OLARTE, ANTONIO ZORZANO;MIAN, ALEC;CLAUZEL, LUC MARTI;EXPOSITO, MIRIAM ROYO;FONT, FRANCESC YRAOLA;PALOMERA, FERNANDO ALBERICIO |